Apimeds Pharmaceuticals US, Inc (APUS)
$4.75-1.86%Close
SELLCRISIS · day 75
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $7M
- Avg volume
- 62.3K
- Beta
- 0.15
- P/E (TTM)
- -0.10
- Short % float
- 4.76%
- Days to cover
- 1.0
- SI change
- -84.8%
- 1W
- +10.98%
- 1M
- -15.93%
- 3M
- -68.33%
- YTD
- -71.47%
- vs SPY 1W
- +12.17%
- vs SPY 1M
- -19.25%
- vs SPY 3M
- -70.72%
- vs SPY YTD
- -83.23%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- VNDABUYVanda Pharmaceuticals Inc.RECOVERYQ 13$5.33+0.95%
- GLSIBUYGreenwich LifeSciences, Inc.RECOVERYQ 27$17.58+5.46%
- ENVBSELLEnveric Biosciences, Inc.CRISISQ -8$1.41-1.40%
- ARDXSELLArdelyx, Inc.CRISISQ 1$3.74-3.86%
- ORGOSELLOrganogenesis Holdings Inc.CRISISQ 5$1.67-7.22%
- STROSELLSutro Biopharma, Inc.CRISISQ -6$20.49-2.61%
- MDGLSELLMadrigal Pharmaceuticals, Inc.RECOVERYQ 16$511.97-0.92%
- PHIOBUYPhio Pharmaceuticals Corp.RECOVERYQ 3$1.17-0.85%
- BLTEBUYBelite Bio, IncRECOVERYQ 54$158.87-1.36%
- CELCSELLCelcuity Inc.RECOVERYQ 29$90.79-2.93%
- DMRABUYGalecto, Inc.RECOVERYQ -3$30.31-1.65%
- ZURABUYZura Bio LimitedRECOVERYQ 13$6.30+7.69%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
